This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Angèle Moryusef: Innovator in Cardiac Treatment
Introduction
Angèle Moryusef is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of acute coronary syndromes. His work has the potential to improve patient outcomes in critical cardiac procedures.
Latest Patents
Moryusef holds a patent for the use of otamixaban in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting. This invention relates to otamixaban or a pharmaceutically acceptable salt thereof, showcasing his innovative approach to addressing serious health conditions.
Career Highlights
Angèle Moryusef is associated with Sanofi, a leading global healthcare company. His role at Sanofi has allowed him to work on groundbreaking research and development projects that aim to enhance therapeutic options for patients.
Collaborations
Moryusef collaborates with various professionals in the medical field, including his coworker Christophe Gaudin. Their combined expertise contributes to the advancement of medical treatments and innovations.
Conclusion
Angèle Moryusef's contributions to cardiac treatment through his patent on otamixaban highlight his role as an innovator in the medical field. His work at Sanofi and collaborations with other professionals underscore the importance of teamwork in advancing healthcare solutions.